1,046 followers
New Research: Neoadjuvant chemoradiotherapy with camrelizumab in patients with locally advanced esophageal squamous cell carcinoma: Background Neoadjuvant anti-programmed death receptor-1 (PD-1) blockade has been reported to improve the… https://t.co/1r6z